Journal of Virus Eradication

SJR Rank #9,468H-index: 22SJR: 0.621Best quartile: Q2Open AccessAPC: US$2,950Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • EpidemiologyQ2
  • Infectious DiseasesQ2
  • Public Health, Environmental and Occupational HealthQ2
  • VirologyQ2
  • ImmunologyQ3

Areas: Immunology and Microbiology · Medicine

Most published research topics

HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHepatitis C virus researchHIV-related health complications and treatmentsImmune Cell Function and InteractionHepatitis B Virus StudiesCytomegalovirus and herpesvirus researchHIV, Drug Use, Sexual RiskVirus-based gene therapy research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

2022202509182736

Detailed Information

ISSN

2055-6659, 2055-6640

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.29

References per Document

45.52

Coverage

2015-2026

Scope

The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions. The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. All submissions are peer reviewed by experts who work at major international centers of excellence. The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections. The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.

Metrics from SCImago Journal Rank 2025. View on SCImago